SeaCrest Wealth Management’s Foundation Medicine FMI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
– Sell
-264
Closed -$36K – 2396
2018
Q2
$36K Hold
264
– – 0.01% 1125
2018
Q1
$21K Buy
264
+120
+83% +$8.86K ﹤0.01% 1321
2017
Q4
$10K Buy
+144
New +$7.47K ﹤0.01% 1616

SeaCrest Wealth Management's FMI Position: Q3 2018 in Review

SeaCrest Wealth Management sold out of Foundation Medicine (FMI) in Q3 2018, closing a stake of 264 shares — an estimated $36K sold.

SeaCrest Wealth Management first reported a position in FMI in Q4 2017 and held it in 3 quarters. The position peaked at $36K in Q2 2018. 0 funds tracked by Wall St. Rank hold FMI as of Q3 2018.

  • SeaCrest Wealth Management reported no remaining Foundation Medicine position as of Q3 2018 after selling out during the quarter.
  • SeaCrest Wealth Management sold 264 Foundation Medicine shares in Q3 2018, an estimated $36K.
  • SeaCrest Wealth Management first reported a position in Foundation Medicine in Q4 2017 and held it in 3 quarters.
  • SeaCrest Wealth Management's Foundation Medicine position peaked at $36K in Q2 2018.
  • 0 funds tracked by Wall St. Rank held Foundation Medicine as of Q3 2018.

Based on SeaCrest Wealth Management's 13F filing for Q3 2018, filed 14 Nov 2018.